NSEClarification - Financial Results24 Jun 2026 · 24 Jun 2026, 06:18 pm

Clarification - Financial Results

Vaishali Pharma Limited · VAISHALI

✦ AI SummaryResults

Vaishali Pharma Limited has been asked by the NSE to clarify its financial results for the quarter ended 31-Mar-2026, specifically regarding the non-submission of the consolidated statement of cash flow.

Analysis Scores

Earnings Impact5/10
Growth Catalyst1/10
Governance Concern2/10
Regulatory Risk6/10
Balance Sheet Risk3/10
Liquidity Impact5/10
Market Sentiment4/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

The Exchange has sought clarification from Vaishali Pharma Limited for the quarter ended 31-Mar-2026 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Consolidated Statement of Cash Flow not submitted The response of the Company is awaited.